Association between hemochromatosis genotype and lead exposure among elderly men: The Normative Aging Study

Environmental Health Perspectives

Volumn 112, Issue 6, 2004, Pages 746-750

  Wright, Robert O ^a,b,c   Silverman, Edwin K ^b,d   Schwartz, Joel ^b,c   Tsaih, Shring Wern ^b,c   Senter, Jody ^b,d   Sparrow, David ^e   Weiss, Scott T ^b,d   Aro, Antonio ^b,c   Hu, Howard ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d PARTNERS HEALTHCARE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Hemochromatosis; Lead; Men; Metals

Indexed keywords

DNA; GENE PRODUCT; LEAD;

AGE; AGED; AGING; ALLELE; ARTICLE; BIOACCUMULATION; BODY BURDEN; BONE LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EDUCATION; EXPOSURE; GENDER; GENE CONTROL; GENETIC VARIABILITY; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; IRON METABOLISM; IRON STORAGE; LEAD BLOOD LEVEL; LEAD POISONING; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATELLA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; TIBIA; TISSUE LEVEL; TOXICOKINETICS; WILD TYPE; X RAY FLUORESCENCE;

EID: 2442421209     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6581     Document Type: Article

References (37)

1. Akesson A, Stal P, Vahter M. 2000. Phlebotomy increases cadmium uptake in hemochromatosis. Environ Health Perspect 108:289-291.
2. ASHG. 1996. Statement on informed consent for genetic research. The American Society of Human Genetics. Am J Hum Genet 59(2):471-474.
3. Barton JC, Conrad ME, Nuby S, Harrison L. 1978. Effects of iron in the absorption and retention of lead. J Lab Clin Med 92:536-547.
4. Barton JC, Patton MA, Edwards CQ, Griffen LM, Kushner JP, Meeks RG, et al. 1994. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med 124(2):193-198.
5. Bell B, Rose CL, Damon H. 1972. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 3:5-17.
6. Beutler E. 1997. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 61(3):762-764.
7. Bradley LA, Johnson DD, Palomaki GE, Haddow JE, Robertson NH, Ferrie RM. 1998. Hereditary haemochromatosis mutation frequencies in the general population. J Med Screening 5(1):34-36.
8. Bradman A, Eskenazi B, Sutton P, Athanasoulis M, Goldman LR. 2001. Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ Health Perspect 109:1079-1084.
9. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. 1998. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 280(2):172-178.
10. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, De Sousa M, et al. 1998. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243(3):203-208.
11. Chisolm JJ Jr, Thomas DJ, Hamill TG. 1985. Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children. Clin Chem 31(4):601-605.
12. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJ, et al. 1995. Informed consent for genetic research on stored tissue samples. JAMA 274(22):1786-1792.
13. Cox TM, Kelly AL. 1998. Haemochromatosis: an inherited metal and toxicity syndrome. Curr Opin Genet Dev 8(3):274-281.
14. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B. 1998. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 44(12):2429-2432.
15. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13(4):399-408.
16. Garry PJ, Montoya GD, Baumgartner RN, Liang HC, Williams TM, Brodie SG. 1997. Impact of HLA-H mutations on iron stores in healthy elderly men and women. Blood Cells Mol Dis 23(2):277-287.
17. Graziano JH, Popovac D, Factor-Litvak P, Shrout P, Kline J, Murphy MJ, et al. 1990. Determinants of elevated blood lead during pregnancy in a population surrounding a lead smelter in Kosovo, Yugoslavia. Environ Health Perspect 89:95-100.
18. Hammad TA, Sexton M, Langenberg P. 1996, Relationship between blood lead and dietary iron intake in preschool children: a cross-sectional study. Ann Epidemiol 6:30-33.
19. Hu H. 1998. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect 106:961-967.
20. Hu H, Milder F, Burger DE. 1991. The use of K-X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens, and measurement uncertainty. Environ Health Perspect 94:107-110.
21. Hu H, Payton M, Korrick S, Aro A, Sparrow D, Weiss ST, Rotnitzky A. 1996. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men: the Normative Aging Study. Am J Epidemiol 144:749-759.
22. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
23. Hu H, Wu MT, Chang Y, Sparrow D, Weiss S, Kelsey K. 2001. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect 109:827-832.
24. Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V. 1997. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Human Genet 100(5-6):544-547.
25. Mahaffey KR, Gartside PS, Glueck CJ. 1986. Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976 to 1980. Pediatrics 78(2):257-262.
26. Mahaffey-Six K, Goyer RA. 1972. The influence of iron deficiency on tissue content and toxicity of ingested lead in the rat. J Lab Clin Med 79:128-136.
27. McLaren GD, Nathanson MH, Jacobs A, Trevett D, Thomson W. 1991. Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J Lab Clin Med 117(5):390-401.
28. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Nørgaard-Pedersen B, Robson KJ. 1999. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13(2):154-159.
29. Onalaja AO, Claudio L. 2000. Genetic susceptibility to lead poisoning. Environ Health Perspect 108(suppl 1):23-28.
30. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, et al. 1998. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Int Med 129(11):954-961.
31. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. 2000b. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 108:949-954.
32. Schwartz BS, Stewart WF, Kelsey KT, Simon D, Park S, Links JM, et al. 2000a. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organo-lead manufacturing workers. Environ Health Perspect 108:199-203.
33. Smith CM, Wang X, Hu H, Kelsey KT. 1995. A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253.
34. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, et al. 1997. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 94(23):12384-12389.
35. Wetmur JG, Lehnert G, Desnick RJ. 1997. The delta-aminole-vulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56(2):109-119.
36. Wright RO. 1999. The role of iron therapy in childhood plumbism. Curr Opin Pediatr 11(3):255-258.
37. Wright RO, Shannon MW, Wright RJ, Hu H. 1999. Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health 89(7):1049-1053.